Stay updated on SPRINTER Clinical Trial
Sign up to get notified when there's something new on the SPRINTER Clinical Trial page.

Latest updates to the SPRINTER Clinical Trial page
- Check5 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe site footer’s revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden message and a Home link, indicating restricted access, and replaces the previous rich study-detail content with a minimal error page.SummaryDifference18%

- Check40 days agoChange DetectedTel Litwinsky, Israel, 5265601 was added to the study's locations. Qiryat Krinitzi, Israel, 5265601 was removed from the study's locations.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded recruitment site Qiryat Krinitzi, Israel (5265601) and updated the study document to revision v3.6.6. Removed Tel Litwinsky, Israel (5265601) as a location and updated from revision v3.6.5.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision bumped from v3.6.4 to v3.6.5, indicating a newer release of the page content. This update appears to be a metadata/version change rather than a change to the study details or terms presented on the page.SummaryDifference0.0%

Stay in the know with updates to SPRINTER Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINTER Clinical Trial page.